Patents by Inventor Brent Steven McKenzie

Brent Steven McKenzie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neurological conditions
    Patent number: 9364534
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF or G-CSFR, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: June 14, 2016
    Assignee: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick Curwen, Eugene Maraskovsky
  • Treatment of neurological conditions
    Patent number: 9352038
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: May 31, 2016
    Assignee: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick Curwen, Eugene Maraskovsky
  • TREATMENT OF NEUROLOGICAL CONDITIONS
    Publication number: 20140234303
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Application
    Filed: March 24, 2014
    Publication date: August 21, 2014
    Applicant: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick CURWEN, Eugene MARASKOVSKY
  • Relay vaccine
    Patent number: 8349575
    Abstract: The present invention provides a method and composition for raising an immune response in an animal. The method comprising administering to the animal a composition comprising a carrier and an antigen bound to a targeting moiety. The targeting moiety binds to at least one receptor that is upregulated on lymphocytes that home to MAdCAM+ mucosal lymphoid tissues.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: January 8, 2013
    Assignee: The Council of the Queensland Institute of Medical Research (QIMR)
    Inventors: Brent Steven McKenzie, Jefferey Stephen Boyle, Andrew Mark Lew
  • RELAY VACCINE
    Publication number: 20110165181
    Abstract: The present invention provides a method and composition for raising an immune response in an animal. The method comprising administering to the animal a composition comprising a carrier and an antigen bound to a targeting moiety. The targeting moiety binds to at least one receptor that is upregulated on lymphocytes that home to MAdCAM+ mucosal lymphoid tissues.
    Type: Application
    Filed: February 17, 2011
    Publication date: July 7, 2011
    Inventors: Brent Steven McKenzie, Jefferey Stephen Boyle, Andrew Mark Lew
  • TREATMENT OF NEUROLOGICAL CONDITIONS
    Publication number: 20110091456
    Abstract: The present invention is directed to a method for treating an inflammatory neurodegenerative condition of the CNS in a subject comprising administering to said subject a G-CSF or G-CSFR inhibiting agent selected from the group consisting of an antibody specific for G-CSF or G-CSFR, a soluble G-CSFR or a G-CSF-binding portion thereof and a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF.
    Type: Application
    Filed: September 14, 2010
    Publication date: April 21, 2011
    Applicant: CSL LIMITED
    Inventors: Brent Steven McKenzie, Peter Frederick CURWEN, Eugene MARASKOVSKY